Skip to main content
Premium Trial:

Request an Annual Quote

Protea Inks Four Distribution Deals

NEW YORK (GenomeWeb News) – Bioanalytical firm Protea Biosciences today announced four distribution deals.

The Morgantown, W.Va.-based company said that it has inked deals with Yair Technologies for the distribution of Protea products in Israel; with BioAnalytic covering Poland; with Irida Iberica covering Spain and Portugal; and with IDL Teknolojik covering Turkey.

The partners will distribute Protea's sample preparation and mass spectrometry products and its LAESI DP-1000 sample analysis instrument, Protea Vice President and General Manager Alessandro Baldi said.

Financial and other terms of the deal were not disclosed.

Earlier this year Protea and Waters announced a co-marketing deal to offer Waters' SYNAPT G2 and G2-S HDMS systems with the LAESI DP-1000 system.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.